You are viewing: Rest Of Europe Microbiology Testing Market analysis
Part of: Microbiology Testing Market (Global)

The Rest Of Europe Microbiology Testing Market was valued at $144.9 Million in 2025 and projected to reach to $188.1 Million by 2030, representing a compound annual growth rate of 4.5%. The Rest Of Europe microbiology testing market demonstrates resilient growth potential, supported by increasing healthcare investments and modernization of diagnostic infrastructure across the region.

Rest Of Europe Microbiology Testing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Microbiology Testing Market Trends and Insights

  • Rest Of Europe encompasses diverse healthcare systems and regulatory frameworks that drive steady demand for diagnostic microbiology services across clinical laboratories, hospitals, and pharmaceutical quality control facilities.
  • The region's aging population and increasing prevalence of infectious diseases are key factors supporting market expansion throughout the forecast period. Rest Of Europe's microbiology testing sector benefits from rising healthcare expenditure, modernization of laboratory infrastructure, and growing adoption of automated testing platforms.
  • Between 2025 and 2030, Rest Of Europe is expected to see accelerated investment in point-of-care testing and molecular diagnostics, driven by regulatory harmonization efforts and cross-border healthcare initiatives.
  • The market's moderate growth trajectory reflects both the maturity of established healthcare systems in Rest Of Europe and emerging opportunities in less-developed regional markets..

Key Market Statistics

  • CAGR (2025-2030) 4.5% CAGR
  • Market Size, 2025 ~USD 144.9 Million
  • Forecast, 2030 ~USD 188.1 Million
  • Country Rest Of Europe

Rest Of Europe Microbiology Testing Market Overview

Market Valuation :

Rest Of Europe microbiology testing market is valued at USD 144.9 million in 2025, with steady growth trajectory driven by diverse healthcare systems across the region.

Growth Trajectory :

The market is projected to reach USD 188.1 million by 2030, representing a CAGR of 4.5%, reflecting consistent demand for diagnostic microbiology services across clinical settings.

Regulatory Landscape :

Rest Of Europe encompasses varied regulatory frameworks that influence microbiology testing adoption, creating both opportunities and challenges for market participants across different countries.

End-User Diversity :

Demand spans clinical laboratories, hospitals, and pharmaceutical companies, with each sector contributing to the region's microbiology testing market expansion through distinct testing requirements.

Rest Of Europe Microbiology Testing Market Dynamics

  • Clinical laboratories and hospitals are expanding their microbiology capabilities to meet rising demand for infectious disease diagnostics and antimicrobial resistance monitoring.
  • The diverse regulatory environments across Rest Of Europe countries present opportunities for localized solutions and partnerships. Pharmaceutical companies operating in the region continue to drive demand for quality control and safety testing services.
  • Healthcare system improvements and growing awareness of diagnostic accuracy are expected to sustain market momentum through 2030.
  • Regional players are increasingly focusing on technological advancement and compliance with varying national standards to capture market share..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Rest Of Europe's microbiology testing market will grow from USD 144.9M (2025) to USD 188.1M (2030) at a 4.5% CAGR.
    • Rest Of Europe's diverse regulatory landscape and aging demographics drive consistent demand for diagnostic microbiology services.
    • Automation and molecular diagnostics adoption are accelerating in Rest Of Europe's laboratory infrastructure modernization efforts.
    • Rest Of Europe represents a stable, mature market with emerging growth opportunities in point-of-care and molecular testing segments.

    Microbiology Testing Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment VIRAL (Pathogen Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.3% from 2025 to 2030
    Largest Segment TRADITIONAL MICROBIOLOGY METHODS (TMM) (Technology Type)
    Market Size Base Year (Billions) ~USD 7.4 (2025)
    Revenue Forecast (Billions) ~USD 9.58 (2030)
    Segments Covered Product, Type, Technology Type, Pathogen Type, End User, Technology, End Users

    Rest Of Europe Microbiology Testing Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments
    • Reagents & Kits

    By Type

    • Automated Culture Systems
    • Cellular Component-Based Rapid Microbiology Testing
    • Colony Counters
    • Culture Methods
    • Growth-Based Rapid Microbiology Testing
    • Incubators
    • Manual Counting Methods
    • Mass Spectrometers
    • Microscopes
    • Microscopy Methods
    • Nucleic Acid-Based Rapid Microbiology Testing
    • Other Instruments
    • Other Traditional Microbiology Methods
    • Staining Techniques
    • Viability-Based Rapid Microbiology Testing

    By Technology Type

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By Pathogen Type

    • Bacterial
    • Fungal
    • Other Pathogens
    • Viral

    By End User

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    By Technology

    • Rapid Microbiology Methods (Rmm)
    • Traditional Microbiology Methods (Tmm)

    By End Users

    • Cosmetics & Personal Care Companies
    • Environmental & Water Testing
    • Food & Beverage Companies
    • Other End Users
    • Pharmaceutical & Biotech Companies

    Target Audience

    • In Vitro Diagnostics Manufacturers : Need Rest Of Europe-specific market data to develop localized product strategies, identify distribution partnerships, and allocate R&D resources for regional microbiology testing solutions.
    • Clinical Laboratory Operators : Require market insights to justify equipment investments, benchmark service offerings against regional competitors, and plan capacity expansion in microbiology testing departments.
    • Healthcare Consultants : Utilize Rest Of Europe market data to advise hospital networks and diagnostic centers on microbiology testing adoption, technology upgrades, and operational efficiency improvements.
    • Pharmaceutical Quality Assurance Teams : Need regional market intelligence to evaluate outsourcing options for microbiology testing services and identify qualified contract laboratories across Rest Of Europe.
    • Healthcare Investment Firms : Require detailed market forecasts and regional growth metrics to evaluate investment opportunities in diagnostic companies, laboratory networks, and microbiology testing infrastructure.

    Key Companies in the Rest Of Europe Microbiology Testing Market

    CompanyHQOwnershipStrongest segments
    BIOMÉRIEUXFrancePublic CompanySyndromic and low-plex PCR (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE),Microbiology ID/AST and blood culture (VITEK 2, VITEK MS, VITEK REVEAL, BACT/ALERT, ETEST, API),Immunoassays and sepsis markers (VIDAS, Hybiome CLIA),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    MERCK KGAAGermanyPublic CompanyLife Science (lab and bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials),
    NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals,
    QIAGENNetherlandsPublic CompanySample technology consumables and instruments,Immune response (TB and transplant/viral load assays),Oncology and sexual/reproductive health assays,
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyLife Science instruments and systems,Life Science reagents and consumables,Clinical diagnostic test systems and informatics,
    BRUKERUnited StatesPublic CompanyNMR/EPR and Preclinical Imaging (BSI BioSpin),Mass Spectrometry, Molecular Diagnostics, and CALID Solutions,X-ray, AFM, and Nano-Analysis (BSI Nano),
    SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems,Industrial and Vacuum Machinery,
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    EUROFINS SCIENTIFICLuxembourgPublic CompanyFood and Feed Testing, Assurance and Certification,Environment Testing (water, air, soil, waste, maritime),Biopharma Services and Clinical Diagnostics,
    IDEXXUnited StatesPublic CompanyCompanion Animal Group (in-clinic analyzers, SNAP tests, reference labs, telemedicine, software),Water Quality Products,Livestock, Poultry and Dairy plus Human Diagnostics,

    BIOMÉRIEUX

    bioMérieux is a French public company founded in 1963 that employs 14,894 people. The company operates in the life sciences and diagnostics sector.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a major player in the life sciences and laboratory services industry.

    MERCK KGAA

    Merck KGaA is a German public company with roots dating back to 1668 and currently employs 59,077 people. The company operates across pharmaceuticals, life sciences, and specialty chemicals.

    NEOGEN CORPORATION

    Neogen Corporation is a United States-based public company founded in 1981 with 2,974 employees. The company provides food and animal safety solutions.

    QIAGEN

    QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company specializes in molecular diagnostics and life sciences technologies.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.

    BRUKER

    Bruker is a United States-based public company founded in 1960 with 11,085 employees. The company develops scientific instruments and analytical solutions for research and diagnostics.

    SHIMADZU CORPORATION

    Shimadzu Corporation is a Japanese public company founded in 1875 with 14,649 employees. The company manufactures analytical and measuring instruments, medical devices, and industrial equipment.

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services for drug development.

    EUROFINS SCIENTIFIC

    Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.

    IDEXX

    IDEXX is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostics and software for veterinary and water testing markets.

    Reasons to Buy this Report

    • Regional Market Sizing : Obtain precise valuation data specific to Rest Of Europe microbiology testing market, enabling accurate budget allocation and investment decisions for regional expansion strategies.
    • Growth Forecasting : Access detailed 5-year projections (2025-2030) with 4.5% CAGR insights to plan product launches, capacity investments, and market entry timing across Rest Of Europe.
    • Regulatory Intelligence : Understand diverse regulatory frameworks across Rest Of Europe countries to navigate compliance requirements and identify market-specific opportunities for microbiology testing solutions.
    • Competitive Positioning : Benchmark your organization against regional market dynamics and identify gaps in clinical laboratories, hospitals, and pharmaceutical sectors to strengthen competitive advantage.
    • Stakeholder Alignment : Present data-driven insights to investors, boards, and partners with region-specific market intelligence that demonstrates growth potential and strategic value in Rest Of Europe.

    Frequently asked questions

    What is the market size of microbiology testing in Rest Of Europe?

    Rest Of Europe's microbiology testing market is estimated at USD 144.9 million in 2025 and is forecast to reach USD 188.1 million by 2030.

    What is the growth rate for microbiology testing in Rest Of Europe?

    Rest Of Europe's microbiology testing market is projected to grow at a CAGR of 4.5% between 2025 and 2030.

    What factors are driving growth in Rest Of Europe's microbiology testing market?

    Rest Of Europe's market growth is driven by an aging population, rising infectious disease prevalence, increased healthcare spending, laboratory modernization, and adoption of automated and molecular diagnostic platforms.

    Which segments are growing fastest in Rest Of Europe's microbiology testing market?

    In Rest Of Europe, point-of-care testing and molecular diagnostics are among the fastest-growing segments, supported by regulatory harmonization and healthcare infrastructure investments.

    How does Rest Of Europe's microbiology testing market compare to other European regions?

    Rest Of Europe represents a mature, stable market with moderate growth; its performance reflects diverse healthcare systems and regulatory frameworks across the region's varied economies.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics of the microbiology testing sector, including drivers, opportunities, restraints, challenges, and key player strategies. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape is evaluated to assess market players across various parameters within the broad categories of business and product strategy. The market size is estimated using top-down and bottom-up approaches, while market breakdown and data triangulation methods are employed to determine segment and subsegment sizes.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources included industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of the industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    Microbiology Testing Market Size, and Share

    Note 1: Others include sales managers, marketing managers, and product managers.
    Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both the top-down and bottom-up approaches have been used to estimate and validate the size of the small satellite market.

    The top-down and bottom-up approaches were used to estimate and validate the total size of the microbiology testing market. These methods were also widely used to estimate the sizes of various market segments. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research.
    • The revenues generated by leading players operating in the microbiology testing industry have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Microbiology Testing Market : Top-Down and Bottom-Up Approach

    Microbiology Testing Market Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall market size using the above-mentioned process, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides.

    Market Definition

    Microbiology testing involves the identification, quantification, and analysis of microorganisms, including bacteria, viruses, fungi, and protozoa, and plays a critical role in ensuring product safety, protecting public health, and preserving environmental integrity. These tests are widely used across pharmaceutical and biotech companies, food and beverage companies, environmental and water testing, cosmetics and personal-care companies, the agriculture and animal feed industry, and academic and research institutes, where they support quality control, regulatory compliance, contamination monitoring, and scientific research activities.

    Key Stakeholders

    • Manufacturers & distributors of microbiology testing solutions
    • Food & beverage companies
    • Environmental and water testing organizations
    • Pharmaceutical & biotechnology companies
    • Cosmetics & personal care companies
    • Agriculture & animal feed industry
    • Contract testing laboratories
    • Academic & research institutes
    • Government and regulatory bodies
    • Market research & consulting firms
    • Venture capitalists & investors

    Report Objectives

    • To define, segment, and forecast the global microbiology testing market by product, technology, pathogen type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall microbiology testing market 
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the microbiology testing market using the company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    Available customizations:

    MarketsandMarkets offers the following customizations for this market report.

    Company Profiles

    • An additional five company profiles of players operating in microbiology testing.

    Regional Analysis

    • Further breakdown of the market segments at the country level

    Country Information

    • Additional country-level analysis of microbiology testing

     

    Get the Full Microbiology Testing Market Report

    Full forecast, segment splits, and company analysis for all Microbiology Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status